Medstar Research Institute

Washington D.C., District of Columbia 20010

0 studies enrolling now · 11 studies all time

What they study most

Diabetes, Diabetes Mellitus, Type 2, Diabetes Type 2, Epilepsy, Hyperlipidemia, Hypoglycemia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic Syndrome, Post-traumatic Epilepsy, Soft Tissue Sarcoma, Type 2 Diabetes

Studies at this site

• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
• Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D) — Completed
• Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS — Completed
• Levetiracetam to Prevent Post-Traumatic Epilepsy — Completed
• Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus — Completed
• Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma — Completed
• How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics — Completed
• Screening for Early Evidence of Diabetes — Completed
• Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus — Completed
• Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment — Completed
• A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator — Completed